RA
Readystate Asset Management LP
13F filer · CIK 0001900923Reported Aug 14, 2026
Net buyer this quarter
13F portfolio value$2.93BU.S. long equity reported on 13F
Positions452229 new · 121 closed
Net flow last quarter+$467MBuys minus sells
Top 10 positions weight14.1%Concentration
Holdings
13F · last 4 quarters freeScroll for earlier quarters
| Company | Value | % of portfolio | % of company | POSITION CHANGE qoq % | First reported |
|---|---|---|---|---|---|
| Q2 2026Reported Aug 14, 2026452 positions | |||||
| $103M | 3.51% | 0.15% | +132.1% | Q4 2022 | |
| $55.4M | 1.89% | 0.08% | -4.2% | Q4 2023 | |
| $46.4M | 1.58% | 0.13% | +104.1% | Q4 2024 | |
| $34M | 1.16% | 1.42% | +23.4% | Q1 2025 | |
| $32.2M | 1.10% | 0.31% | +19.6% | Q4 2025 | |
| $30M | 1.03% | 0.01% | +353.2% | Q1 2026 | |
| $29.8M | 1.02% | 0.01% | Not reported | Q2 2024 | |
| $28.2M | 0.96% | 0.02% | Not reported | Q1 2025 | |
| $27.5M | 0.94% | 2.45% | New | Q2 2026 | |
| $27.2M | 0.93% | 0.00% | +46.5% | Q4 2024 | |
| LBLBRDKLiberty Broadband Corp | $24.8M | 0.85% | Not reported | +108.4% | Q1 2024 |
| $24M | 0.82% | 0.07% | +18.9% | Q4 2023 | |
| $22.9M | 0.78% | Not reported | +322.4% | Q2 2024 | |
| $22.7M | 0.78% | 1.47% | +259.2% | Q1 2026 | |
| $22.4M | 0.76% | 0.11% | Not reported | Q3 2024 | |
| $21.2M | 0.72% | 0.34% | -18.3% | Q3 2025 | |
| $20.5M | 0.70% | 0.05% | +685.8% | Q4 2023 | |
| $20.2M | 0.69% | 0.22% | +131.8% | Q4 2025 | |
| $20.1M | 0.69% | 0.03% | Not reported | Q4 2023 | |
| $18.9M | 0.64% | 0.23% | New | Q2 2026 | |
| $18.5M | 0.63% | 0.58% | -20.6% | Q4 2025 | |
| $18.5M | 0.63% | 0.02% | Not reported | Q2 2024 | |
| $16.9M | 0.58% | 0.06% | +165.8% | Q4 2023 | |
| $16.5M | 0.56% | Not reported | New | Q2 2026 | |
| $16.4M | 0.56% | 0.86% | -4.5% | Q4 2022 | |
| $16M | 0.55% | 41100.00% | New | Q2 2026 | |
| $15.3M | 0.52% | 0.26% | New | Q2 2026 | |
| $15.1M | 0.52% | 0.14% | Not reported | Q4 2022 | |
| $13.2M | 0.45% | Not reported | +1464.5% | Q1 2026 | |
| $12.9M | 0.44% | 3.79% | New | Q2 2026 | |
| $12.7M | 0.43% | 0.41% | Not reported | Q1 2024 | |
| $12.6M | 0.43% | Not reported | +32.6% | Q1 2026 | |
| $12.6M | 0.43% | 0.56% | Not reported | Q4 2024 | |
| $12.6M | 0.43% | 0.15% | New | Q2 2026 | |
| $12.3M | 0.42% | 4.85% | Not reported | Q3 2024 | |
| $11.5M | 0.39% | 0.04% | +263.0% | Q3 2023 | |
| $11.5M | 0.39% | 0.08% | Not reported | Q2 2024 | |
| $10.3M | 0.35% | 1.15% | +197.4% | Q2 2025 | |
| $10.3M | 0.35% | 0.05% | Not reported | Q3 2023 | |
| $9.31M | 0.32% | 0.28% | Not reported | Q4 2024 | |
| $9.14M | 0.31% | 0.06% | +155.2% | Q4 2024 | |
| $9.07M | 0.31% | 0.11% | +332.5% | Q2 2023 | |
| $8.69M | 0.30% | 0.01% | +380.4% | Q4 2024 | |
| $8.34M | 0.28% | 0.72% | New | Q2 2026 | |
| $8.21M | 0.28% | 0.06% | Not reported | Q1 2025 | |
| $8.08M | 0.28% | 0.07% | +6.1% | Q1 2026 | |
| $7.78M | 0.27% | 0.04% | +7.1% | Q2 2025 | |
| $7.6M | 0.26% | 0.59% | +89.8% | Q4 2022 | |
| $7.47M | 0.26% | 0.00% | +28.4% | Q1 2025 | |
| $7.43M | 0.25% | 0.01% | Not reported | Q1 2023 | |
| Q1 2026Reported May 15, 2026344 positions | |||||
| $52.8M | 2.37% | 0.08% | Not reported | Q4 2023 | |
| $45.6M | 2.05% | 0.07% | +424.7% | Q4 2022 | |
| STSLNOSoleno Therapeutics Inc | $31.9M | 1.43% | 1.84% | +8.9% | Q4 2024 |
| MMASIMasimo Corp | $30.4M | 1.37% | 0.33% | Not reported | Q4 2023 |
| $28.5M | 1.28% | 1.15% | -29.4% | Q1 2025 | |
| $26.9M | 1.21% | 0.06% | -67.3% | Q4 2024 | |
| $26.7M | 1.20% | 0.41% | Not reported | Q3 2025 | |
| $22.5M | 1.01% | 0.26% | +111.0% | Q4 2025 | |
| EAEAElectronic Arts Inc. | $19.3M | 0.87% | Not reported | Not reported | Q2 2023 |
| $18.2M | 0.82% | 0.06% | +76.8% | Q4 2023 | |
| LBLBRDKLiberty Broadband Corp | $18M | 0.81% | Not reported | -17.4% | Q1 2024 |
| $17.3M | 0.78% | 0.91% | +45.8% | Q4 2022 | |
| $14.3M | 0.64% | 0.03% | Not reported | Q4 2022 | |
| $14.2M | 0.64% | 0.11% | New | Q1 2026 | |
| $13.9M | 0.62% | Not reported | New | Q1 2026 | |
| $11.2M | 0.50% | 4.87% | +2.5% | Q3 2024 | |
| $10.8M | 0.49% | 0.20% | -52.0% | Q2 2023 | |
| $10.7M | 0.48% | Not reported | New | Q1 2026 | |
| $10.4M | 0.47% | 0.31% | New | Q1 2026 | |
| $10.3M | 0.46% | 0.11% | Not reported | Q1 2024 | |
| $10.1M | 0.46% | 0.13% | -22.3% | Q2 2023 | |
| $10M | 0.45% | 0.00% | +220.0% | Q3 2023 | |
| $9.95M | 0.45% | Not reported | +202.5% | Q2 2023 | |
| $8.28M | 0.37% | 0.00% | New | Q1 2026 | |
| $8.25M | 0.37% | 0.80% | +39.6% | Q4 2025 | |
| $7.48M | 0.34% | 0.40% | New | Q1 2026 | |
| $7.32M | 0.33% | 0.02% | Not reported | Q4 2023 | |
| $6.89M | 0.31% | Not reported | Not reported | Q2 2024 | |
| $6.71M | 0.30% | 0.00% | +154.3% | Q1 2024 | |
| $6.53M | 0.29% | Not reported | -81.3% | Q1 2025 | |
| $6.52M | 0.29% | 0.66% | New | Q1 2026 | |
| $6.18M | 0.28% | 0.12% | -3.1% | Q4 2023 | |
| $5.9M | 0.27% | 0.01% | Not reported | Q4 2024 | |
| $5.86M | 0.26% | 0.01% | Not reported | Q2 2024 | |
| $5.84M | 0.26% | 0.00% | Not reported | Q4 2023 | |
| $5.83M | 0.26% | 0.00% | +96.2% | Q3 2023 | |
| $5.57M | 0.25% | 0.00% | -20.0% | Q3 2025 | |
| $5.43M | 0.24% | 0.00% | Not reported | Q4 2024 | |
| $5.18M | 0.23% | 0.09% | -58.3% | Q4 2025 | |
| $5.08M | 0.23% | 0.00% | +94.8% | Q1 2025 | |
| $5.02M | 0.23% | 0.03% | +26.5% | Q1 2024 | |
| $5M | 0.22% | 0.00% | Not reported | Q4 2023 | |
| $4.91M | 0.22% | 0.00% | +69.7% | Q1 2024 | |
| $4.76M | 0.21% | 0.33% | New | Q1 2026 | |
| $4.7M | 0.21% | Not reported | New | Q1 2026 | |
| $4.54M | 0.20% | 0.00% | New | Q1 2026 | |
| $4.47M | 0.20% | 0.04% | Not reported | Q2 2025 | |
| $4.45M | 0.20% | 0.07% | New | Q1 2026 | |
| $4.44M | 0.20% | 0.01% | Not reported | Q4 2023 | |
| $4.38M | 0.20% | 0.31% | +15.7% | Q4 2022 | |
| Q4 2025Reported Feb 17, 2026301 positions | |||||
| $72M | 2.92% | 0.20% | Not reported | Q4 2024 | |
| $42.5M | 1.72% | 0.04% | Not reported | Q2 2023 | |
| STSLNOSoleno Therapeutics Inc | $40.5M | 1.64% | 1.67% | +324.9% | Q4 2024 |
| $39.6M | 1.61% | 1.63% | +39.8% | Q1 2025 | |
| $26.9M | 1.09% | 0.42% | Not reported | Q3 2025 | |
| $26.1M | 1.06% | 0.10% | -70.5% | Q1 2025 | |
| LBLBRDKLiberty Broadband Corp | $21.1M | 0.85% | Not reported | +28.2% | Q1 2024 |
| $20M | 0.81% | 0.42% | +40.5% | Q2 2023 | |
| $18M | 0.73% | 0.30% | New | Q4 2025 | |
| $17.1M | 0.69% | 0.31% | +140.1% | Q3 2023 | |
| $16M | 0.65% | 1.09% | New | Q4 2025 | |
| $15.7M | 0.63% | 0.63% | -4.5% | Q4 2022 | |
| $15.1M | 0.61% | Not reported | +299.3% | Q1 2025 | |
| $14.4M | 0.59% | 0.04% | New | Q4 2025 | |
| $13.3M | 0.54% | 4.75% | Not reported | Q3 2024 | |
| $12.9M | 0.52% | 0.12% | New | Q4 2025 | |
| $12.2M | 0.50% | 1.47% | -7.8% | Q3 2024 | |
| $11.4M | 0.46% | 0.10% | Not reported | Q1 2023 | |
| $11.3M | 0.46% | 0.17% | +41.6% | Q2 2023 | |
| $10.8M | 0.44% | 0.15% | -66.3% | Q3 2025 | |
| $10.3M | 0.42% | 0.03% | Not reported | Q4 2023 | |
| $9.49M | 0.38% | Not reported | +504.0% | Q1 2025 | |
| $9.32M | 0.38% | 0.12% | +995.9% | Q4 2023 | |
| $9.12M | 0.37% | 0.01% | Not reported | Q4 2022 | |
| $8.92M | 0.36% | 0.47% | New | Q4 2025 | |
| $8.65M | 0.35% | 0.58% | New | Q4 2025 | |
| $8.22M | 0.33% | Not reported | +45.8% | Q1 2025 | |
| $7.8M | 0.32% | 0.10% | -13.9% | Q4 2023 | |
| $7.74M | 0.31% | 0.64% | -38.8% | Q3 2023 | |
| $7.36M | 0.30% | 0.49% | +72.8% | Q4 2024 | |
| $7.23M | 0.29% | 0.18% | +59.6% | Q4 2023 | |
| $6.25M | 0.25% | 10.11% | +49.1% | Q1 2024 | |
| $6.22M | 0.25% | 0.00% | Not reported | Q3 2025 | |
| $6.07M | 0.25% | 0.10% | Not reported | Q2 2023 | |
| $6.02M | 0.24% | Not reported | Not reported | Q4 2024 | |
| $5.89M | 0.24% | 0.54% | -25.3% | Q3 2023 | |
| $5.77M | 0.23% | Not reported | New | Q4 2025 | |
| $5.66M | 0.23% | 1.68% | +63.6% | Q2 2023 | |
| $5.45M | 0.22% | 0.18% | +5.4% | Q3 2025 | |
| $5.36M | 0.22% | 0.04% | Not reported | Q2 2025 | |
| $5.2M | 0.21% | 0.06% | Not reported | Q2 2023 | |
| $5.05M | 0.20% | 3.81% | +7.7% | Q3 2023 | |
| $5.03M | 0.20% | Not reported | New | Q4 2025 | |
| $5M | 0.20% | Not reported | New | Q4 2025 | |
| $4.83M | 0.20% | Not reported | +30.0% | Q4 2024 | |
| $4.83M | 0.20% | Not reported | New | Q4 2025 | |
| $4.79M | 0.19% | Not reported | Not reported | Q4 2024 | |
| $4.79M | 0.19% | 0.61% | New | Q4 2025 | |
| $4.57M | 0.19% | 0.03% | +26.8% | Q2 2023 | |
| $4.53M | 0.18% | Not reported | +102.8% | Q4 2024 | |
| Q3 2025Reported Nov 7, 2025257 positions | |||||
| $47.6M | 2.03% | 0.33% | -3.4% | Q1 2025 | |
| $32M | 1.36% | Not reported | New | Q3 2025 | |
| VPVRNAVerona Pharma plc | $28M | 1.19% | 0.04% | +376.9% | Q2 2025 |
| $25.8M | 1.10% | 0.42% | New | Q3 2025 | |
| $23.5M | 1.00% | 1.60% | +38.0% | Q3 2024 | |
| SASPRSpirit AeroSystems Holdings, Inc. | $22.7M | 0.97% | 0.50% | +1.3% | Q2 2023 |
| MMRUSMerus N.V. | $22.5M | 0.96% | 0.31% | +204.1% | Q2 2025 |
| LBLBRDKLiberty Broadband Corp | $21.5M | 0.92% | Not reported | +42.4% | Q1 2024 |
| CBCOOPCooperative Bankshares Inc | $18.3M | 0.78% | Not reported | New | Q3 2025 |
| $16.4M | 0.70% | 0.29% | +2.0% | Q2 2023 | |
| $16M | 0.68% | 0.10% | -34.9% | Q1 2024 | |
| $15.9M | 0.68% | 1.04% | Not reported | Q3 2023 | |
| $15.8M | 0.67% | 4.73% | +19.2% | Q3 2024 | |
| $15.4M | 0.66% | 1.44% | -2.6% | Q1 2025 | |
| $14M | 0.60% | 0.65% | +105.4% | Q4 2022 | |
| STSLNOSoleno Therapeutics Inc | $13.9M | 0.59% | 0.38% | -47.6% | Q4 2024 |
| $13.7M | 0.59% | 0.20% | Not reported | Q1 2023 | |
| $12.7M | 0.54% | 0.06% | New | Q3 2025 | |
| $12.4M | 0.53% | 0.24% | -52.5% | Q2 2025 | |
| SSRDXSurmodics Inc | $11.4M | 0.49% | 2.68% | -11.7% | Q2 2025 |
| ATAKROAkero Therapeutics, Inc. | $11.3M | 0.48% | 0.30% | -62.9% | Q1 2025 |
| $11M | 0.47% | 3.34% | +1296.2% | Q2 2025 | |
| $10.2M | 0.44% | 0.12% | New | Q3 2025 | |
| $9.63M | 0.41% | 0.35% | -9.6% | Q3 2023 | |
| $9.3M | 0.40% | 0.12% | +1.9% | Q2 2023 | |
| $8.87M | 0.38% | 0.07% | Not reported | Q1 2025 | |
| $7.88M | 0.34% | Not reported | +248.9% | Q1 2025 | |
| $7.83M | 0.33% | 0.12% | +7.8% | Q4 2023 | |
| $6.91M | 0.29% | 0.13% | Not reported | Q3 2023 | |
| $6.82M | 0.29% | 3.54% | -2.2% | Q3 2023 | |
| $6.82M | 0.29% | 0.08% | -14.1% | Q2 2024 | |
| $6.77M | 0.29% | 0.57% | +5.6% | Q2 2025 | |
| $6.64M | 0.28% | 0.13% | +32.8% | Q3 2024 | |
| $6.63M | 0.28% | 0.00% | Not reported | Q1 2024 | |
| $6.17M | 0.26% | 1.36% | -15.7% | Q1 2024 | |
| $6.1M | 0.26% | 0.06% | -51.3% | Q4 2024 | |
| $6.02M | 0.26% | 0.17% | New | Q3 2025 | |
| $5.79M | 0.25% | 0.52% | New | Q3 2025 | |
| $5.73M | 0.24% | 1.17% | +534.1% | Q4 2023 | |
| $5.69M | 0.24% | Not reported | +40.5% | Q1 2025 | |
| $5.66M | 0.24% | 0.36% | +14.1% | Q4 2024 | |
| $5.64M | 0.24% | 0.72% | -34.6% | Q3 2023 | |
| $5.54M | 0.24% | 0.09% | +961.9% | Q4 2022 | |
| APAPLSApellis Pharmaceuticals, Inc. | $5.48M | 0.23% | 0.19% | Not reported | Q1 2024 |
| $4.93M | 0.21% | 0.11% | +1632.5% | Q4 2023 | |
| $4.76M | 0.20% | 0.10% | -64.8% | Q3 2023 | |
| $4.59M | 0.20% | 0.13% | Not reported | Q4 2023 | |
| HHOLXHologic Inc | $4.16M | 0.18% | 0.03% | Not reported | Q2 2023 |
| $3.71M | 0.16% | 0.02% | +5.2% | Q1 2024 | |
| $3.7M | 0.16% | 1.03% | -14.8% | Q2 2023 | |
Premium opens every quarter this fund has filed